Permanent URL to this publication: http://dx.doi.org/10.5167/uzh-64701
Beil, J; Fairbairn, L; Pelczar, P; Buch, T (2012). Is BAC transgenesis obsolete? State of the art in the era of designer nucleases. Journal of Biomedicine and Biotechnology, 2012:308414.
DNA constructs based on bacterial artificial chromosomes (BACs) are frequently used to generate transgenic animals as they reduce the influence of position effects and allow predictable expression patterns for genes whose regulatory sequences are not fully identified. Despite these advantages BAC transgenics suffer from drawbacks such as complicated vector construction, low efficiency of transgenesis, and some remaining expression variegation. The recent development of transcription activator-like effector nucleases (TALENs) and zinc finger nucleases (ZFNs) has resulted in new transgenic techniques which do not have the drawbacks associated with BAC transgenesis. Initial reports indicate that such designer nucleases (DNs) allow the targeted insertion of transgenes into endogenous loci by direct injection of the targeting vector and mRNA/DNA encoding the predesigned nucleases into oocytes. This results in the transgene being inserted at a specific locus in the mouse genome, thus circumventing the drawbacks associated with BAC transgenesis.
|Item Type:||Journal Article, refereed, further contribution|
|Communities & Collections:||05 Vetsuisse Faculty > Institute of Laboratory Animal Science
04 Faculty of Medicine > Institute of Laboratory Animal Science
|DDC:||570 Life sciences; biology
610 Medicine & health
|Deposited On:||19 Sep 2012 08:59|
|Last Modified:||17 Jan 2014 02:36|
|Publisher:||Hindawi Publishing Corporation|
|Citations:||Web of Science®. Times Cited: 1|
Scopus®. Citation Count: 1
Users (please log in): suggest update or correction for this item
Repository Staff Only: item control page